Biotechnology
The Biotechnology industry has a total of 600 stocks, with a combined market cap of $1.11 trillion and total revenue of $105.29 billion.
Market Cap
1.11T
Revenue
105.29B
Profits
-41.72B
PE Ratio
n/a
Profit Margin
-39.62%
Dividend Yield
0.04%
600 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 115.36B | -1.29% | 1,344,392 | 11.72B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 77.86B | -1.18% | 946,266 | 14.25B |
| 3 | ARGX | argenx SE | 49.64B | 1.82% | 380,028 | 3.68B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 48.88B | -0.26% | 1,624,943 | 3.21B |
| 5 | ONC | BeOne Medicines AG | 38.85B | 5.11% | 359,104 | 4.97B |
| 6 | INSM | Insmed Incorporated | 34.92B | -2.38% | 3,727,082 | 447.02M |
| 7 | BNTX | BioNTech SE | 26.90B | 4.90% | 1,595,924 | 3.70B |
| 8 | RPRX | Royalty Pharma plc | 23.30B | 0.25% | 4,907,090 | 2.35B |
| 9 | RVMD | Revolution Medicines, Inc. | 23.19B | 2.37% | 3,870,581 | - |
| 10 | GMAB | Genmab A/S | 20.59B | -0.24% | 2,053,127 | 3.85B |
| 11 | INCY | Incyte Corporation | 20.31B | -2.73% | 2,039,596 | 4.81B |
| 12 | ROIV | Roivant Sciences Ltd. | 16.30B | 5.78% | 11,806,111 | 20.33M |
| 13 | MRNA | Moderna, Inc. | 15.47B | 17.02% | 24,652,739 | 2.23B |
| 14 | BBIO | BridgeBio Pharma, Inc. | 15.25B | 2.95% | 2,625,178 | 353.78M |
| 15 | ASND | Ascendis Pharma A/S | 13.21B | 3.08% | 1,359,416 | 758.59M |
| 16 | SMMT | Summit Therapeutics Inc. | 12.96B | -1.35% | 4,087,197 | - |
| 17 | IONS | Ionis Pharmaceuticals, Inc. | 12.87B | -2.67% | 1,884,850 | 966.96M |
| 18 | EXEL | Exelixis, Inc. | 11.87B | 0.05% | 2,077,616 | 2.29B |
| 19 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.22B | -3.26% | 430,282 | 740.64M |
| 20 | RNA | Avidity Biosciences, Inc. | 10.91B | 0.11% | 1,169,827 | 20.87M |
| 21 | BMRN | BioMarin Pharmaceutical Inc. | 10.60B | -4.35% | 2,522,961 | 3.09B |
| 22 | TECH | Bio-Techne Corporation | 10.34B | -0.27% | 3,098,284 | 1.22B |
| 23 | JAZZ | Jazz Pharmaceuticals plc | 9.87B | -0.76% | 1,044,518 | 4.16B |
| 24 | ABVX | ABIVAX Société Anonyme | 9.42B | 1.39% | 1,787,089 | 6.23M |
| 25 | ARWR | Arrowhead Pharmaceuticals, Inc. | 9.01B | -0.58% | 2,580,526 | 829.45M |
| 26 | AXSM | Axsome Therapeutics, Inc. | 8.79B | -1.41% | 587,329 | 561.26M |
| 27 | KRYS | Krystal Biotech, Inc. | 8.47B | 7.28% | 509,648 | 373.16M |
| 28 | HALO | Halozyme Therapeutics, Inc. | 8.43B | -1.04% | 968,110 | 1.24B |
| 29 | NUVL | Nuvalent, Inc. | 7.86B | 2.03% | 562,338 | - |
| 30 | CYTK | Cytokinetics, Incorporated | 7.74B | -2.03% | 1,713,043 | 87.21M |
| 31 | PRAX | Praxis Precision Medicines, Inc. | 7.70B | 1.85% | 519,149 | 7.46M |
| 32 | CAI | Caris Life Sciences, Inc. | 7.45B | 3.12% | 3,124,646 | 649.06M |
| 33 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.19B | 2.77% | 452,121 | 174.33M |
| 34 | PTCT | PTC Therapeutics, Inc. | 6.05B | -2.82% | 2,367,593 | 1.78B |
| 35 | PCVX | Vaxcyte, Inc. | 6.02B | 0.39% | 767,952 | - |
| 36 | KYMR | Kymera Therapeutics, Inc. | 5.93B | 1.42% | 668,102 | 43.74M |
| 37 | BLTE | Belite Bio, Inc | 5.89B | 1.40% | 198,914 | - |
| 38 | CRNX | Crinetics Pharmaceuticals, Inc. | 5.57B | -1.88% | 878,360 | 1.54M |
| 39 | GPCR | Structure Therapeutics Inc. | 5.39B | 12.34% | 3,421,790 | - |
| 40 | COGT | Cogent Biosciences, Inc. | 5.37B | 1.50% | 2,101,804 | - |
| 41 | CRSP | CRISPR Therapeutics AG | 5.35B | 1.59% | 1,539,334 | 38.34M |
| 42 | APGE | Apogee Therapeutics, Inc. | 5.33B | 1.74% | 675,069 | - |
| 43 | IMVT | Immunovant, Inc. | 5.31B | 1.43% | 1,570,846 | - |
| 44 | PTGX | Protagonist Therapeutics, Inc. | 5.09B | 1.38% | 798,961 | 209.22M |
| 45 | CELC | Celcuity Inc. | 4.82B | -0.29% | 438,095 | - |
| 46 | MIRM | Mirum Pharmaceuticals, Inc. | 4.67B | 1.05% | 749,037 | 471.79M |
| 47 | ACAD | ACADIA Pharmaceuticals Inc. | 4.48B | -0.49% | 1,140,778 | 1.05B |
| 48 | SRRK | Scholar Rock Holding Corporation | 4.46B | 0.44% | 1,859,145 | - |
| 49 | FOLD | Amicus Therapeutics, Inc. | 4.43B | 0.28% | 9,103,150 | 598.70M |
| 50 | CGON | CG Oncology, Inc. | 4.24B | -2.12% | 989,173 | 2.17M |
| 51 | ADMA | ADMA Biologics, Inc. | 4.21B | -1.28% | 2,889,453 | 488.56M |
| 52 | LEGN | Legend Biotech Corporation | 4.17B | -4.77% | 2,294,238 | 909.05M |
| 53 | TGTX | TG Therapeutics, Inc. | 4.07B | 0.54% | 3,398,319 | 531.90M |
| 54 | ACLX | Arcellx, Inc. | 3.86B | 2.90% | 520,702 | 35.90M |
| 55 | CORT | Corcept Therapeutics Incorporated | 3.82B | -2.70% | 1,239,024 | 741.17M |
| 56 | TERN | Terns Pharmaceuticals, Inc. | 3.75B | 1.00% | 2,206,372 | - |
| 57 | LGND | Ligand Pharmaceuticals Incorporated | 3.72B | -8.72% | 939,386 | 251.23M |
| 58 | NAMS | NewAmsterdam Pharma Company N.V. | 3.61B | -2.54% | 590,814 | 35.24M |
| 59 | VERA | Vera Therapeutics, Inc. | 3.49B | 5.68% | 1,595,299 | - |
| 60 | VKTX | Viking Therapeutics, Inc. | 3.47B | -3.37% | 5,146,492 | - |
| 61 | BEAM | Beam Therapeutics Inc. | 3.41B | 2.55% | 2,383,083 | 55.70M |
| 62 | LQDA | Liquidia Corporation | 3.31B | 4.07% | 2,055,306 | 69.22M |
| 63 | CNTA | Centessa Pharmaceuticals plc | 3.25B | 0.91% | 726,821 | 15.00M |
| 64 | TARS | Tarsus Pharmaceuticals, Inc. | 3.21B | 0.26% | 345,606 | 366.10M |
| 65 | ARQT | Arcutis Biotherapeutics, Inc. | 3.19B | -2.73% | 2,023,553 | 317.93M |
| 66 | XENE | Xenon Pharmaceuticals Inc. | 3.12B | -2.11% | 698,864 | 7.50M |
| 67 | IDYA | IDEAYA Biosciences, Inc. | 3.08B | -4.75% | 759,542 | 214.83M |
| 68 | VRDN | Viridian Therapeutics, Inc. | 3.05B | -1.78% | 1,291,519 | 70.79M |
| 69 | IRON | Disc Medicine, Inc. | 2.85B | -4.53% | 596,583 | - |
| 70 | DNLI | Denali Therapeutics Inc. | 2.83B | 0.89% | 1,225,132 | - |
| 71 | RCUS | Arcus Biosciences, Inc. | 2.81B | 6.76% | 3,097,245 | 240.00M |
| 72 | DYN | Dyne Therapeutics, Inc. | 2.81B | -2.41% | 2,348,181 | - |
| 73 | IBRX | ImmunityBio, Inc. | 2.78B | 8.88% | 32,757,831 | 82.56M |
| 74 | ADPT | Adaptive Biotechnologies Corporation | 2.76B | -1.04% | 1,846,174 | 252.75M |
| 75 | ALMS | Alumis Inc. | 2.76B | 4.84% | 4,658,668 | 22.12M |
| 76 | CPRX | Catalyst Pharmaceuticals, Inc. | 2.75B | -3.75% | 1,922,582 | 578.20M |
| 77 | APLS | Apellis Pharmaceuticals, Inc. | 2.70B | -8.06% | 4,023,286 | 1.02B |
| 78 | EWTX | Edgewise Therapeutics, Inc. | 2.64B | 3.40% | 756,959 | - |
| 79 | MLYS | Mineralys Therapeutics, Inc. | 2.61B | -0.12% | 2,027,881 | - |
| 80 | TVTX | Travere Therapeutics, Inc. | 2.60B | -14.63% | 20,121,158 | 435.83M |
| 81 | WVE | Wave Life Sciences Ltd. | 2.60B | 2.23% | 4,227,826 | 109.23M |
| 82 | AAPG | Ascentage Pharma Group International | 2.56B | -3.17% | 1,741 | 54.52M |
| 83 | TLX | Telix Pharmaceuticals Limited | 2.49B | -1.32% | 243,953 | 664.23M |
| 84 | SYRE | Spyre Therapeutics, Inc. | 2.45B | -3.87% | 656,356 | - |
| 85 | RXRX | Recursion Pharmaceuticals, Inc. | 2.44B | -2.49% | 18,948,475 | 43.69M |
| 86 | MESO | Mesoblast Limited | 2.35B | -4.87% | 416,753 | 17.20M |
| 87 | RARE | Ultragenyx Pharmaceutical Inc. | 2.32B | -1.07% | 3,544,656 | 630.60M |
| 88 | SRPT | Sarepta Therapeutics, Inc. | 2.25B | 1.51% | 3,154,039 | 2.41B |
| 89 | NUVB | Nuvation Bio Inc. | 2.25B | 1.39% | 9,936,103 | 26.75M |
| 90 | SLNO | Soleno Therapeutics, Inc. | 2.23B | -0.07% | 1,837,554 | 98.68M |
| 91 | IMNM | Immunome, Inc. | 2.22B | -2.09% | 2,665,040 | 9.68M |
| 92 | OCUL | Ocular Therapeutix, Inc. | 2.22B | -2.43% | 3,993,575 | 55.78M |
| 93 | OLMA | Olema Pharmaceuticals, Inc. | 2.19B | -3.13% | 1,041,389 | - |
| 94 | GLPG | Galapagos NV | 2.19B | 0.41% | 158,828 | 336.64M |
| 95 | ERAS | Erasca, Inc. | 2.13B | 20.47% | 9,428,630 | - |
| 96 | ZLAB | Zai Lab Limited | 2.08B | 1.79% | 694,692 | 441.63M |
| 97 | HRMY | Harmony Biosciences Holdings, Inc. | 2.06B | -6.56% | 1,244,759 | 825.94M |
| 98 | MAZE | Maze Therapeutics, Inc. | 1.99B | 2.99% | 511,423 | 2.50M |
| 99 | AUPH | Aurinia Pharmaceuticals Inc. | 1.98B | -1.90% | 1,158,101 | 265.81M |
| 100 | DNTH | Dianthus Therapeutics, Inc. | 1.92B | 14.67% | 1,684,747 | 3.08M |
| 101 | NRIX | Nurix Therapeutics, Inc. | 1.92B | 2.99% | 1,791,983 | 83.69M |
| 102 | GLUE | Monte Rosa Therapeutics, Inc. | 1.90B | 1.14% | 1,383,531 | 181.54M |
| 103 | VCEL | Vericel Corporation | 1.87B | 1.26% | 633,009 | 258.72M |
| 104 | ZYME | Zymeworks Inc. | 1.79B | 3.28% | 946,705 | 134.48M |
| 105 | SNDX | Syndax Pharmaceuticals, Inc. | 1.78B | -1.21% | 1,188,971 | 111.30M |
| 106 | UPB | Upstream Bio, Inc. | 1.76B | 2.97% | 829,178 | 2.80M |
| 107 | KOD | Kodiak Sciences Inc. | 1.76B | 0.93% | 689,949 | - |
| 108 | STOK | Stoke Therapeutics, Inc. | 1.75B | 3.94% | 631,475 | 205.63M |
| 109 | MNKD | MannKind Corporation | 1.73B | -2.25% | 2,905,759 | 313.79M |
| 110 | CLDX | Celldex Therapeutics, Inc. | 1.72B | 1.01% | 855,342 | 2.60M |
| 111 | ARDX | Ardelyx, Inc. | 1.71B | -4.35% | 5,042,316 | 398.23M |
| 112 | PHVS | Pharvaris N.V. | 1.69B | -0.38% | 189,623 | - |
| 113 | NBY | NovaBay Pharmaceuticals, Inc. | 1.64B | -3.05% | 1,417,571 | 10.30M |
| 114 | SION | Sionna Therapeutics, Inc. | 1.64B | 1.29% | 235,633 | - |
| 115 | IMCR | Immunocore Holdings plc | 1.63B | -1.04% | 285,678 | 379.59M |
| 116 | MBX | MBX Biosciences, Inc. | 1.63B | -0.44% | 816,008 | - |
| 117 | AGIO | Agios Pharmaceuticals, Inc. | 1.62B | -1.84% | 658,676 | 44.79M |
| 118 | FTRE | Fortrea Holdings Inc. | 1.60B | -5.60% | 825,485 | 2.76B |
| 119 | TYRA | Tyra Biosciences, Inc. | 1.54B | 0.14% | 437,522 | - |
| 120 | ELVN | Enliven Therapeutics, Inc. | 1.53B | 2.88% | 1,033,663 | - |
| 121 | ORKA | Oruka Therapeutics, Inc. | 1.52B | 2.12% | 390,982 | - |
| 122 | PGEN | Precigen, Inc. | 1.48B | 0.85% | 3,411,965 | 6.31M |
| 123 | MNMD | Mind Medicine (MindMed) Inc. | 1.46B | 7.13% | 3,221,612 | - |
| 124 | INVA | Innoviva, Inc. | 1.46B | 0.36% | 898,393 | 388.52M |
| 125 | BHVN | Biohaven Ltd. | 1.46B | -7.35% | 3,411,826 | - |
| 126 | TRVI | Trevi Therapeutics, Inc. | 1.45B | - | 1,060,744 | - |
| 127 | SVRA | Savara Inc. | 1.43B | 2.60% | 1,099,018 | - |
| 128 | NVAX | Novavax, Inc. | 1.41B | 11.87% | 11,124,493 | 1.06B |
| 129 | TNGX | Tango Therapeutics, Inc. | 1.41B | -2.06% | 2,040,914 | 66.50M |
| 130 | RLAY | Relay Therapeutics, Inc. | 1.38B | 1.79% | 1,228,119 | 8.36M |
| 131 | NTLA | Intellia Therapeutics, Inc. | 1.36B | 2.71% | 7,918,553 | 57.53M |
| 132 | TSHA | Taysha Gene Therapies, Inc. | 1.34B | 0.82% | 2,851,348 | 6.31M |
| 133 | QURE | uniQure N.V. | 1.34B | -6.68% | 2,411,251 | 15.75M |
| 134 | ATAI | AtaiBeckley Inc. | 1.33B | -2.39% | 3,850,580 | 3.02M |
| 135 | ANAB | AnaptysBio, Inc. | 1.33B | -1.85% | 329,077 | 169.47M |
| 136 | OCS | Oculis Holding AG | 1.33B | -0.43% | 269,578 | 992.00K |
| 137 | EYPT | EyePoint, Inc. | 1.32B | -0.06% | 866,739 | 42.34M |
| 138 | RAPP | Rapport Therapeutics, Inc. | 1.29B | 0.37% | 486,961 | - |
| 139 | CAPR | Capricor Therapeutics, Inc. | 1.28B | 1.14% | 729,788 | 11.13M |
| 140 | XERS | Xeris Biopharma Holdings, Inc. | 1.28B | -2.03% | 2,214,901 | 266.14M |
| 141 | ABCL | AbCellera Biologics Inc. | 1.28B | -5.53% | 7,023,474 | 35.33M |
| 142 | IMTX | Immatics N.V. | 1.26B | 2.40% | 296,063 | 99.45M |
| 143 | SANA | Sana Biotechnology, Inc. | 1.25B | 2.62% | 2,397,763 | - |
| 144 | PVLA | Palvella Therapeutics, Inc. | 1.23B | 3.04% | 107,693 | - |
| 145 | PHAT | Phathom Pharmaceuticals, Inc. | 1.22B | 8.02% | 1,428,001 | 147.19M |
| 146 | MLTX | MoonLake Immunotherapeutics | 1.22B | -5.47% | 1,800,406 | - |
| 147 | PHAR | Pharming Group N.V. | 1.22B | -4.05% | 31,503 | 362.27M |
| 148 | SEPN | Septerna, Inc. | 1.18B | 6.03% | 221,101 | 22.05M |
| 149 | ZBIO | Zenas BioPharma, Inc. | 1.16B | 9.05% | 1,413,755 | 15.00M |
| 150 | AKTS | Aktis Oncology, Inc. | 1.12B | -1.84% | 292,454 | 5.56M |
| 151 | SPRY | ARS Pharmaceuticals, Inc. | 1.12B | -0.62% | 1,943,811 | 142.77M |
| 152 | IVA | Inventiva S.A. | 1.09B | 4.77% | 564,279 | 19.93M |
| 153 | DAWN | Day One Biopharmaceuticals, Inc. | 1.09B | -6.53% | 4,203,327 | 133.67M |
| 154 | INBX | Inhibrx Biosciences, Inc. | 1.07B | -3.50% | 224,244 | 1.40M |
| 155 | TBPH | Theravance Biopharma, Inc. | 1.03B | 3.46% | 386,158 | 80.33M |
| 156 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.03B | 2.03% | 1,420,148 | 192.44M |
| 157 | NBTX | Nanobiotix S.A. | 1.02B | 6.53% | 51,187 | 11.93M |
| 158 | XNCR | Xencor, Inc. | 995.46M | -1.62% | 516,804 | 150.13M |
| 159 | VTYX | Ventyx Biosciences, Inc. | 994.46M | 0.14% | 5,684,447 | - |
| 160 | CMPX | Compass Therapeutics, Inc. | 992.47M | 7.10% | 3,318,220 | 850.00K |
| 161 | ORIC | ORIC Pharmaceuticals, Inc. | 987.53M | 10.82% | 3,115,988 | - |
| 162 | GHRS | GH Research PLC | 982.55M | 4.14% | 532,729 | - |
| 163 | BCAX | Bicara Therapeutics Inc. | 960.33M | 0.57% | 290,777 | - |
| 164 | RAPT | RAPT Therapeutics, Inc. | 943.83M | -0.84% | 175,849 | - |
| 165 | IOVA | Iovance Biotherapeutics, Inc. | 932.87M | -2.08% | 10,566,050 | 250.43M |
| 166 | URGN | UroGen Pharma Ltd. | 928.22M | -7.55% | 986,687 | 96.52M |
| 167 | ANNX | Annexon, Inc. | 922.66M | 11.33% | 2,792,538 | - |
| 168 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 920.67M | -9.16% | 710,211 | - |
| 169 | ABUS | Arbutus Biopharma Corporation | 911.62M | 5.33% | 1,031,336 | 14.61M |
| 170 | AVBP | ArriVent BioPharma, Inc. | 906.95M | 7.49% | 413,264 | - |
| 171 | OMER | Omeros Corporation | 894.76M | -1.56% | 2,171,962 | - |
| 172 | VIR | Vir Biotechnology, Inc. | 877.88M | 6.59% | 2,396,438 | 16.86M |
| 173 | DRUG | Bright Minds Biosciences Inc. | 875.69M | 0.83% | 184,649 | - |
| 174 | VALN | Valneva SE | 871.34M | 3.79% | 11,093 | 211.09M |
| 175 | MDXG | MiMedx Group, Inc. | 870.84M | -2.00% | 871,868 | 393.44M |
| 176 | GERN | Geron Corporation | 836.25M | -8.39% | 8,342,004 | 183.40M |
| 177 | YDES | YD Bio Limited | 831.18M | - | 17,273 | 510.36K |
| 178 | JANX | Janux Therapeutics, Inc. | 829.44M | -1.71% | 1,094,773 | 10.00M |
| 179 | KURA | Kura Oncology, Inc. | 801.43M | 0.44% | 1,118,574 | 104.03M |
| 180 | ARVN | Arvinas, Inc. | 789.32M | 1.15% | 497,653 | 312.30M |
| 181 | MPLT | MapLight Therapeutics, Inc. | 769.83M | -7.50% | 139,331 | - |
| 182 | RGNX | REGENXBIO Inc. | 761.88M | -0.20% | 527,604 | 161.32M |
| 183 | KALV | KalVista Pharmaceuticals, Inc. | 755.16M | -8.85% | 1,764,929 | 1.43M |
| 184 | NKTR | Nektar Therapeutics | 744.10M | -5.65% | 1,222,911 | 62.60M |
| 185 | PRME | Prime Medicine, Inc. | 736.48M | -2.80% | 3,146,382 | 5.98M |
| 186 | ATXS | Astria Therapeutics, Inc. | 714.42M | -1.61% | 852,586 | 706.00K |
| 187 | GYRE | Gyre Therapeutics, Inc. | 708.04M | 1.17% | 60,077 | 107.27M |
| 188 | SLS | SELLAS Life Sciences Group, Inc. | 706.67M | 0.97% | 7,853,750 | - |
| 189 | DBVT | DBV Technologies S.A. | 694.56M | -5.02% | 383,846 | 5.50M |
| 190 | CTMX | CytomX Therapeutics, Inc. | 692.99M | -5.76% | 1,612,149 | 113.63M |
| 191 | RIGL | Rigel Pharmaceuticals, Inc. | 689.03M | -5.01% | 489,125 | 282.08M |
| 192 | PROK | ProKidney Corp. | 688.91M | -1.72% | 1,526,316 | 744.00K |
| 193 | FULC | Fulcrum Therapeutics, Inc. | 676.20M | 7.78% | 839,639 | 80.00M |
| 194 | EVMN | Evommune, Inc. | 660.11M | -0.95% | 262,848 | 13.00M |
| 195 | IVVD | Invivyd, Inc. | 659.85M | -4.49% | 4,895,257 | 50.04M |
| 196 | JBIO | Jade Biosciences, Inc. | 634.86M | -0.43% | 205,830 | - |
| 197 | CGEM | Cullinan Therapeutics, Inc. | 633.89M | 1.13% | 327,593 | - |
| 198 | REPL | Replimune Group, Inc. | 630.68M | -0.80% | 807,692 | - |
| 199 | GOSS | Gossamer Bio, Inc. | 615.67M | 5.56% | 5,042,168 | 44.05M |
| 200 | TENX | Tenax Therapeutics, Inc. | 610.58M | 2.38% | 263,339 | - |
| 201 | OCGN | Ocugen, Inc. | 596.53M | 7.30% | 15,571,430 | 5.37M |
| 202 | KROS | Keros Therapeutics, Inc. | 594.09M | 3.28% | 425,943 | 246.72M |
| 203 | MGTX | MeiraGTx Holdings plc | 594.02M | 1.93% | 253,078 | 27.42M |
| 204 | FBRX | Forte Biosciences, Inc. | 579.34M | 9.54% | 332,416 | - |
| 205 | ENGN | enGene Holdings Inc. | 561.33M | 0.96% | 130,928 | - |
| 206 | DRTS | Alpha Tau Medical Ltd. | 559.33M | -7.48% | 651,936 | - |
| 207 | CRMD | CorMedix Inc. | 556.25M | -1.26% | 2,761,975 | 214.30M |
| 208 | VSTM | Verastem, Inc. | 555.71M | 1.27% | 1,104,040 | 13.38M |
| 209 | DNA | Ginkgo Bioworks Holdings, Inc. | 546.76M | 0.63% | 1,019,700 | 180.61M |
| 210 | DSGN | Design Therapeutics, Inc. | 545.71M | 5.04% | 164,520 | - |
| 211 | LXEO | Lexeo Therapeutics, Inc. | 542.30M | -8.50% | 3,086,958 | - |
| 212 | VOR | Vor Biopharma Inc. | 522.34M | -4.66% | 1,158,124 | - |
| 213 | NAGE | Niagen Bioscience, Inc. | 520.58M | 1.72% | 1,104,355 | 124.71M |
| 214 | LENZ | LENZ Therapeutics, Inc. | 519.41M | 6.62% | 748,642 | 17.50M |
| 215 | ANRO | Alto Neuroscience, Inc. | 512.59M | -2.60% | 147,642 | - |
| 216 | LYEL | Lyell Immunopharma, Inc. | 503.69M | -0.25% | 94,991 | 41.00K |
| 217 | ZVRA | Zevra Therapeutics, Inc. | 502.17M | 6.44% | 1,959,010 | 84.39M |
| 218 | LBRX | LB Pharmaceuticals Inc | 500.67M | 3.99% | 280,369 | - |
| 219 | ASMB | Assembly Biosciences, Inc. | 499.82M | 2.17% | 67,133 | 37.19M |
| 220 | ABSI | Absci Corporation | 497.73M | -2.65% | 3,201,258 | 2.82M |
| 221 | KYTX | Kyverna Therapeutics, Inc. | 494.74M | 5.22% | 486,095 | - |
| 222 | CRVS | Corvus Pharmaceuticals, Inc. | 485.43M | -3.70% | 1,443,449 | - |
| 223 | PRTA | Prothena Corporation plc | 483.39M | 0.79% | 470,159 | 11.79M |
| 224 | VTVT | vTv Therapeutics Inc. | 464.96M | 9.82% | 28,211 | 17.00K |
| 225 | ADCT | ADC Therapeutics SA | 458.35M | -3.14% | 503,961 | 75.21M |
| 226 | BCYC | Bicycle Therapeutics plc | 450.20M | -1.37% | 199,761 | 28.34M |
| 227 | FDMT | 4D Molecular Therapeutics, Inc. | 449.08M | 4.80% | 1,076,826 | 120.00K |
| 228 | MNPR | Monopar Therapeutics Inc. | 448.97M | 3.31% | 230,460 | - |
| 229 | IMMP | Immutep Limited | 442.68M | 1.63% | 147,878 | 3.31M |
| 230 | DMAC | DiaMedica Therapeutics Inc. | 441.49M | 1.23% | 125,986 | - |
| 231 | VNDA | Vanda Pharmaceuticals Inc. | 439.68M | 0.40% | 863,363 | 212.07M |
| 232 | ALT | Altimmune, Inc. | 437.71M | -0.99% | 2,601,563 | 20.00K |
| 233 | LXRX | Lexicon Pharmaceuticals, Inc. | 436.08M | 1.69% | 1,529,817 | 70.86M |
| 234 | PRTC | PureTech Health plc | 432.99M | 1.40% | 3,222 | 6.39M |
| 235 | EPRX | Eupraxia Pharmaceuticals Inc. | 421.43M | 1.34% | 172,641 | - |
| 236 | NBP | NovaBridge Biosciences | 420.81M | -1.88% | 427,026 | - |
| 237 | BNTC | Benitec Biopharma Inc. | 416.51M | 1.32% | 119,274 | - |
| 238 | AVXL | Anavex Life Sciences Corp. | 414.58M | 8.16% | 1,874,423 | - |
| 239 | RCKT | Rocket Pharmaceuticals, Inc. | 411.24M | 5.56% | 2,447,803 | - |
| 240 | LCTX | Lineage Cell Therapeutics, Inc. | 404.69M | -5.11% | 827,534 | 10.82M |
| 241 | GLSI | Greenwich LifeSciences, Inc. | 402.06M | 8.16% | 684,532 | - |
| 242 | SLDB | Solid Biosciences Inc. | 402.02M | -1.53% | 1,160,346 | - |
| 243 | CTNM | Contineum Therapeutics, Inc. | 398.17M | 18.87% | 339,239 | - |
| 244 | FHTX | Foghorn Therapeutics Inc. | 391.33M | 4.70% | 322,967 | 24.52M |
| 245 | HELP | Cybin Inc. | 385.76M | 4.74% | 338,810 | - |
| 246 | PEPG | PepGen Inc. | 384.99M | -1.41% | 341,426 | - |
| 247 | ENTA | Enanta Pharmaceuticals, Inc. | 378.97M | 1.70% | 194,270 | 65.32M |
| 248 | TRDA | Entrada Therapeutics, Inc. | 375.11M | 5.13% | 118,240 | 61.52M |
| 249 | TECX | Tectonic Therapeutic, Inc. | 369.65M | 0.77% | 161,275 | - |
| 250 | ALLO | Allogene Therapeutics, Inc. | 368.56M | -1.80% | 4,972,108 | 22.00K |
| 251 | ACIU | AC Immune SA | 366.09M | 5.11% | 456,392 | 5.48M |
| 252 | AUTL | Autolus Therapeutics plc | 364.62M | -8.67% | 3,887,880 | 51.13M |
| 253 | NMRA | Neumora Therapeutics, Inc. | 363.67M | -3.60% | 1,082,471 | - |
| 254 | XFOR | X4 Pharmaceuticals, Inc. | 338.38M | -0.77% | 337,832 | 33.98M |
| 255 | CADL | Candel Therapeutics, Inc. | 336.53M | 4.61% | 885,957 | - |
| 256 | XOMA | XOMA Royalty Corporation | 336.08M | 1.31% | 491,153 | 47.11M |
| 257 | ZURA | Zura Bio Limited | 335.52M | - | 295,986 | - |
| 258 | AARD | Aardvark Therapeutics, Inc. | 335.09M | 3.71% | 323,390 | - |
| 259 | AURA | Aura Biosciences, Inc. | 321.33M | -0.20% | 143,211 | - |
| 260 | AVTX | Avalo Therapeutics, Inc. | 318.42M | 3.18% | 199,915 | 192.00K |
| 261 | PBYI | Puma Biotechnology, Inc. | 314.44M | -0.64% | 358,305 | 212.00M |
| 262 | CAMP | Camp4 Therapeutics Corporation | 314.40M | 0.33% | 70,058 | 3.80M |
| 263 | CLLS | Cellectis S.A. | 303.85M | -0.23% | 25,057 | 82.55M |
| 264 | RLMD | Relmada Therapeutics, Inc. | 297.73M | -1.22% | 607,991 | - |
| 265 | ACHV | Achieve Life Sciences, Inc. | 293.85M | -2.47% | 440,012 | - |
| 266 | ACRS | Aclaris Therapeutics, Inc. | 293.62M | 1.88% | 562,837 | 15.74M |
| 267 | STTK | Shattuck Labs, Inc. | 285.39M | -1.74% | 690,839 | 1.00M |
| 268 | LRMR | Larimar Therapeutics, Inc. | 285.02M | 2.46% | 877,284 | - |
| 269 | PALI | Palisade Bio, Inc. | 281.62M | -0.53% | 2,616,109 | - |
| 270 | SLN | Silence Therapeutics plc | 279.15M | 0.17% | 521,550 | 25.83M |
| 271 | ABEO | Abeona Therapeutics Inc. | 275.83M | -0.20% | 758,236 | 400.00K |
| 272 | GUTS | Fractyl Health, Inc. | 275.46M | 0.50% | 2,445,602 | 3.00K |
| 273 | AVIR | Atea Pharmaceuticals, Inc. | 274.23M | -2.77% | 242,005 | - |
| 274 | OABI | OmniAb, Inc. | 273.52M | -0.52% | 436,784 | 21.09M |
| 275 | HRTX | Heron Therapeutics, Inc. | 271.38M | -0.67% | 1,784,516 | 155.10M |
| 276 | MENS | Jyong Biotech Ltd. | 269.15M | -1.69% | 380,517 | - |
| 277 | IMRX | Immuneering Corporation | 267.00M | -2.01% | 2,565,998 | - |
| 278 | TARA | Protara Therapeutics, Inc. | 263.65M | -6.11% | 2,404,320 | - |
| 279 | NGNE | Neurogene Inc. | 262.55M | -1.91% | 196,860 | 925.00K |
| 280 | FENC | Fennec Pharmaceuticals Inc. | 258.54M | -0.66% | 111,960 | 38.79M |
| 281 | ALDX | Aldeyra Therapeutics, Inc. | 249.07M | 0.24% | 527,570 | - |
| 282 | NAUT | Nautilus Biotechnology, Inc. | 247.56M | -1.51% | 300,529 | - |
| 283 | OBIO | Orchestra BioMed Holdings, Inc. | 241.67M | -8.15% | 154,046 | 2.82M |
| 284 | IMMX | Immix Biopharma, Inc. | 238.18M | 1.80% | 1,192,798 | - |
| 285 | ARMP | Armata Pharmaceuticals, Inc. | 231.18M | -4.94% | 198,992 | 5.05M |
| 286 | RZLT | Rezolute, Inc. | 229.96M | -1.20% | 3,683,627 | - |
| 287 | IKT | Inhibikase Therapeutics, Inc. | 229.80M | -1.75% | 220,426 | 1.00 |
| 288 | ZNTL | Zentalis Pharmaceuticals, Inc. | 225.33M | -0.29% | 1,646,388 | 26.87M |
| 289 | CCCC | C4 Therapeutics, Inc. | 223.87M | 8.45% | 1,716,525 | 30.11M |
| 290 | VYGR | Voyager Therapeutics, Inc. | 223.51M | 3.08% | 673,175 | 31.32M |
| 291 | CBIO | Crescent Biopharma, Inc. | 216.02M | 0.64% | 317,547 | - |
| 292 | ARCT | Arcturus Therapeutics Holdings Inc. | 215.10M | 0.53% | 927,006 | 97.60M |
| 293 | OVID | Ovid Therapeutics Inc. | 214.80M | 2.48% | 1,067,615 | 6.61M |
| 294 | HUMA | Humacyte, Inc. | 214.23M | -1.77% | 4,606,808 | 1.57M |
| 295 | NVCT | Nuvectis Pharma, Inc. | 212.86M | 1.83% | 33,438 | - |
| 296 | MDWD | MediWound Ltd. | 211.55M | -4.24% | 147,504 | 20.93M |
| 297 | ENLV | Enlivex Therapeutics Ltd. | 209.99M | -7.15% | 442,290 | - |
| 298 | ALEC | Alector, Inc. | 209.57M | 4.35% | 738,074 | 69.05M |
| 299 | CABA | Cabaletta Bio, Inc. | 206.97M | -2.71% | 1,403,967 | - |
| 300 | CHRS | Coherus Oncology, Inc. | 205.48M | 3.03% | 1,740,634 | 277.73M |
| 301 | EDIT | Editas Medicine, Inc. | 204.02M | -1.88% | 1,321,374 | 46.38M |
| 302 | SGMT | Sagimet Biosciences Inc. | 201.96M | -0.48% | 563,650 | - |
| 303 | RNAC | Cartesian Therapeutics, Inc. | 199.19M | 5.36% | 121,639 | 1.09M |
| 304 | GALT | Galectin Therapeutics Inc. | 197.93M | -2.85% | 373,523 | - |
| 305 | CLYM | Climb Bio, Inc. | 197.18M | -12.13% | 648,510 | - |
| 306 | MIST | Milestone Pharmaceuticals Inc. | 196.05M | -1.53% | 3,507,132 | - |
| 307 | TNXP | Tonix Pharmaceuticals Holding Corp. | 193.68M | -0.89% | 274,254 | 10.30M |
| 308 | CRDF | Cardiff Oncology, Inc. | 193.32M | - | 470,135 | 501.00K |
| 309 | IPSC | Century Therapeutics, Inc. | 187.72M | 5.39% | 2,133,341 | 113.34M |
| 310 | SABS | SAB Biotherapeutics, Inc. | 187.57M | 5.35% | 553,870 | 114.70K |
| 311 | NTHI | NeOnc Technologies Holdings, Inc. | 186.56M | -0.73% | 61,763 | 59.99K |
| 312 | NERV | Minerva Neurosciences, Inc. | 184.78M | -1.16% | 16,915 | - |
| 313 | PRLD | Prelude Therapeutics Incorporated | 184.57M | 1.82% | 365,817 | 10.50M |
| 314 | CGEN | Compugen Ltd. | 184.26M | -0.51% | 551,697 | 6.90M |
| 315 | SRZN | Surrozen, Inc. | 177.00M | 14.72% | 144,863 | 3.60M |
| 316 | SLGL | Sol-Gel Technologies Ltd. | 175.34M | -0.08% | 27,060 | 18.97M |
| 317 | KLRS | Kalaris Therapeutics, Inc. | 172.81M | 4.52% | 47,512 | - |
| 318 | PRQR | ProQR Therapeutics N.V. | 172.77M | -2.38% | 588,953 | 18.86M |
| 319 | RANI | Rani Therapeutics Holdings, Inc. | 172.56M | -4.70% | 1,393,173 | 1.20M |
| 320 | QNCX | Quince Therapeutics, Inc. | 167.60M | 2.03% | 2,214,793 | - |
| 321 | TNYA | Tenaya Therapeutics, Inc. | 164.33M | 2.96% | 2,723,185 | - |
| 322 | IPHA | Innate Pharma S.A. | 162.84M | 0.93% | 4,444 | 14.84M |
| 323 | PLX | Protalix BioTherapeutics, Inc. | 162.45M | -3.81% | 474,166 | 61.84M |
| 324 | TLSA | Tiziana Life Sciences Ltd | 160.41M | -1.46% | 143,944 | - |
| 325 | AGEN | Agenus Inc. | 156.78M | 8.47% | 1,452,954 | 106.83M |
| 326 | BDTX | Black Diamond Therapeutics, Inc. | 156.68M | 4.17% | 944,702 | 70.00M |
| 327 | ELDN | Eledon Pharmaceuticals, Inc. | 156.32M | 3.14% | 1,020,033 | - |
| 328 | CDXS | Codexis, Inc. | 154.45M | 1.79% | 428,731 | 52.93M |
| 329 | MOLN | Molecular Partners AG | 152.15M | -0.86% | 3,913 | 856.30K |
| 330 | SGMO | Sangamo Therapeutics, Inc. | 150.88M | -0.13% | 2,717,469 | 32.88M |
| 331 | CRBU | Caribou Biosciences, Inc. | 148.61M | 0.63% | 1,033,951 | 9.30M |
| 332 | IRD | Opus Genetics, Inc. | 147.58M | 4.39% | 568,485 | 14.63M |
| 333 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 147.12M | -0.63% | 183,980 | - |
| 334 | NKTX | Nkarta, Inc. | 145.61M | -5.96% | 789,349 | - |
| 335 | KPTI | Karyopharm Therapeutics Inc. | 144.83M | -3.48% | 281,939 | 142.53M |
| 336 | MCRB | Seres Therapeutics, Inc. | 144.47M | 0.82% | 47,900 | 351.00K |
| 337 | TTRX | Turn Therapeutics Inc. | 143.69M | 15.37% | 52,475 | - |
| 338 | VXRT | Vaxart, Inc. | 138.71M | -27.75% | - | 148.20M |
| 339 | SPRO | Spero Therapeutics, Inc. | 138.03M | -2.39% | 167,434 | 40.55M |
| 340 | CNTX | Context Therapeutics Inc. | 137.82M | 0.67% | 1,474,432 | - |
| 341 | ELTX | Elicio Therapeutics, Inc. | 136.48M | 0.90% | 57,227 | - |
| 342 | ORMP | Oramed Pharmaceuticals Inc. | 134.93M | -1.17% | 532,620 | 2.00M |
| 343 | ACOG | Alpha Cognition Inc. | 130.89M | -1.15% | 88,118 | 7.43M |
| 344 | WHWK | Whitehawk Therapeutics, Inc. | 129.60M | 7.00% | 185,215 | 14.38M |
| 345 | UNCY | Unicycive Therapeutics, Inc. | 129.59M | 2.73% | 433,187 | - |
| 346 | ACTU | Actuate Therapeutics, Inc. | 128.30M | -4.00% | 30,212 | - |
| 347 | VRCA | Verrica Pharmaceuticals Inc. | 128.24M | - | 204,308 | 30.83M |
| 348 | CGTX | Cognition Therapeutics, Inc. | 126.23M | -2.72% | 788,878 | - |
| 349 | CNTB | Connect Biopharma Holdings Limited | 121.87M | 2.83% | 63,456 | 762.00K |
| 350 | GNLX | Genelux Corporation | 121.34M | 3.40% | 322,269 | 8.00K |
| 351 | FBIO | Fortress Biotech, Inc. | 121.05M | -7.14% | 7,069,742 | 62.30M |
| 352 | FATE | Fate Therapeutics, Inc. | 117.66M | -4.67% | 1,451,472 | 7.14M |
| 353 | PYXS | Pyxis Oncology, Inc. | 117.06M | -8.74% | 1,928,192 | 2.82M |
| 354 | OKYO | OKYO Pharma Limited | 116.97M | 7.99% | 433,087 | - |
| 355 | HYFT | MindWalk Holdings Corp. | 113.93M | -6.51% | 731,548 | 19.02M |
| 356 | ARTV | Artiva Biotherapeutics, Inc. | 112.91M | -5.74% | 276,042 | 251.00K |
| 357 | RPTX | Repare Therapeutics Inc. | 111.44M | 0.58% | 471,634 | 11.87M |
| 358 | MGNX | MacroGenics, Inc. | 110.70M | -2.23% | 992,573 | 127.63M |
| 359 | CBUS | Cibus, Inc. | 110.07M | 6.84% | 202,764 | 3.79M |
| 360 | INO | Inovio Pharmaceuticals, Inc. | 109.93M | 3.90% | 1,723,879 | 182.34K |
| 361 | ANIX | Anixa Biosciences, Inc. | 109.47M | 3.80% | 391,837 | - |
| 362 | SEER | Seer, Inc. | 107.72M | -1.79% | 73,074 | 16.38M |
| 363 | ONCY | Oncolytics Biotech Inc. | 107.61M | 0.85% | 947,559 | - |
| 364 | BMEA | Biomea Fusion, Inc. | 107.47M | 4.11% | 1,951,080 | - |
| 365 | THAR | Tharimmune, Inc. | 105.33M | -3.99% | 449,192 | - |
| 366 | MREO | Mereo BioPharma Group plc | 105.03M | 16.34% | 38,733,319 | 500.00K |
| 367 | ABOS | Acumen Pharmaceuticals, Inc. | 104.79M | 0.58% | 106,584 | - |
| 368 | SAVA | Cassava Sciences, Inc. | 99.03M | -3.30% | 776,221 | - |
| 369 | DTIL | Precision BioSciences, Inc. | 98.45M | 0.74% | 214,703 | 698.00K |
| 370 | CSBR | Champions Oncology, Inc. | 97.97M | 4.99% | 11,415 | 58.42M |
| 371 | ETHZ | ETHZilla Corporation | 97.91M | 3.62% | 633,016 | 4.11M |
| 372 | COYA | Coya Therapeutics, Inc. | 96.67M | -2.74% | 324,535 | 3.99M |
| 373 | VANI | Vivani Medical, Inc. | 93.38M | - | 86,014 | - |
| 374 | STRO | Sutro Biopharma, Inc. | 90.56M | -6.18% | 101,001 | 105.65M |
| 375 | SPRB | Spruce Biosciences, Inc. | 87.24M | 4.76% | 16,212 | 697.00K |
| 376 | GANX | Gain Therapeutics, Inc. | 85.77M | 4.21% | 841,134 | - |
| 377 | EXOZ | eXoZymes, Inc. | 85.55M | 7.48% | 3,763 | -700.00 |
| 378 | KRRO | Korro Bio, Inc. | 84.66M | 0.56% | 107,477 | 7.37M |
| 379 | ACET | Adicet Bio, Inc. | 83.78M | 6.15% | 112,218 | - |
| 380 | ANVS | Annovis Bio, Inc. | 82.69M | -9.57% | 1,205,484 | - |
| 381 | ATOS | Atossa Therapeutics, Inc. | 82.11M | -2.78% | 538,432 | - |
| 382 | COEP | Coeptis Therapeutics Holdings, Inc. | 81.68M | 3.68% | 79,556 | 501.00K |
| 383 | IMUX | Immunic, Inc. | 81.47M | 2.39% | 1,845,556 | - |
| 384 | ALXO | ALX Oncology Holdings Inc. | 80.78M | 3.47% | 195,233 | - |
| 385 | ADAG | Adagene Inc. | 80.12M | 6.92% | 23,904 | 103.20K |
| 386 | CALC | CalciMedica, Inc. | 79.97M | 2.78% | 106,277 | - |
| 387 | DWTX | Dogwood Therapeutics, Inc. | 79.37M | -11.30% | 119,634 | - |
| 388 | PLRX | Pliant Therapeutics, Inc. | 79.27M | -3.01% | 1,121,220 | - |
| 389 | XBIT | XBiotech Inc. | 78.05M | 1.19% | 19,239 | - |
| 390 | PTHS | Pelthos Therapeutics Inc. | 77.83M | -1.31% | 28,065 | 7.41M |
| 391 | PYPD | PolyPid Ltd. | 73.36M | -5.16% | 71,016 | - |
| 392 | IMA | ImageneBio, Inc. | 72.11M | -1.88% | 4,337 | 800.00K |
| 393 | MNOV | MediciNova, Inc. | 71.26M | 0.69% | 97,035 | 257.92K |
| 394 | CRVO | CervoMed Inc. | 69.77M | -0.66% | 18,026 | 6.16M |
| 395 | ATYR | aTyr Pharma, Inc. | 69.19M | 3.38% | 1,470,980 | 190.00K |
| 396 | KZIA | Kazia Therapeutics Limited | 68.65M | -2.17% | 98,810 | 1.20M |
| 397 | IFRX | InflaRx N.V. | 67.75M | -1.96% | 663,237 | 73.73K |
| 398 | BYSI | BeyondSpring Inc. | 67.03M | -1.81% | 44,722 | 1.88M |
| 399 | EQ | Equillium, Inc. | 66.98M | -4.35% | 417,251 | 4.39M |
| 400 | ENTX | Entera Bio Ltd. | 66.95M | -7.01% | 170,152 | 124.00K |
| 401 | TCRX | TScan Therapeutics, Inc. | 66.40M | - | 387,901 | 8.42M |
| 402 | PSTV | Plus Therapeutics, Inc. | 64.61M | -4.06% | 5,101,842 | 5.26M |
| 403 | MGX | Metagenomi, Inc. | 64.58M | -1.71% | 235,391 | 30.91M |
| 404 | NRXP | NRx Pharmaceuticals, Inc. | 63.06M | -4.05% | 493,546 | 242.00K |
| 405 | TVGN | Tevogen Bio Holdings Inc. | 62.35M | -3.45% | 595,439 | - |
| 406 | PMVP | PMV Pharmaceuticals, Inc. | 61.73M | -0.85% | 184,369 | - |
| 407 | ATHE | Alterity Therapeutics Limited | 61.71M | -3.41% | 6,622 | 3.57M |
| 408 | ANL | Adlai Nortye Ltd. | 60.89M | 3.77% | 51,163 | -1.35M |
| 409 | ICCC | ImmuCell Corporation | 60.15M | -0.30% | 15,683 | 27.77M |
| 410 | MAIA | MAIA Biotechnology, Inc. | 59.31M | -1.27% | 281,437 | - |
| 411 | RADX | Radiopharm Theranostics Limited | 59.15M | 0.39% | 48,678 | 8.20M |
| 412 | LPCN | Lipocine Inc. | 58.13M | 15.95% | 459,551 | 4.32M |
| 413 | IBIO | iBio, Inc. | 57.12M | -5.93% | 1,973,406 | 500.00K |
| 414 | ALGS | Aligos Therapeutics, Inc. | 56.86M | 6.08% | 47,445 | 2.65M |
| 415 | INKT | MiNK Therapeutics, Inc. | 55.39M | -1.67% | 10,148 | - |
| 416 | LITS | Lite Strategy, Inc. | 54.79M | 2.76% | 298,470 | - |
| 417 | GRCE | Grace Therapeutics, Inc. | 54.78M | -1.67% | 104,721 | - |
| 418 | OSTX | OS Therapies Incorporated | 54.23M | 6.94% | 1,070,468 | - |
| 419 | ACRV | Acrivon Therapeutics, Inc. | 53.64M | 4.29% | 1,524,068 | - |
| 420 | PDSB | PDS Biotechnology Corporation | 52.54M | -2.03% | 622,126 | - |
| 421 | NRXS | NeurAxis, Inc. | 52.41M | -4.47% | 72,775 | 3.36M |
| 422 | NTRB | Nutriband Inc. | 52.03M | 1.42% | 18,415 | 2.28M |
| 423 | IBO | Impact BioMedical Inc. | 50.51M | -0.54% | 28,040 | 25.00K |
| 424 | ABVC | ABVC BioPharma, Inc. | 49.50M | 0.96% | 24,694 | 797.92K |
| 425 | TIL | Instil Bio, Inc. | 48.83M | 0.70% | 28,115 | - |
| 426 | PTN | Palatin Technologies, Inc. | 47.18M | 17.09% | 59,129 | 8.85M |
| 427 | NXTC | NextCure, Inc. | 46.84M | -0.15% | 5,371 | - |
| 428 | TELO | Telomir Pharmaceuticals, Inc. | 45.73M | -1.48% | 85,675 | - |
| 429 | ANEB | Anebulo Pharmaceuticals, Inc. | 45.60M | -1.77% | 76,823 | - |
| 430 | KZR | Kezar Life Sciences, Inc. | 45.48M | 1.14% | 26,359 | - |
| 431 | PASG | Passage Bio, Inc. | 45.36M | -20.32% | 99,939 | - |
| 432 | APLM | Apollomics, Inc. | 44.45M | -4.78% | 8,477 | 6.93M |
| 433 | XLO | Xilio Therapeutics, Inc. | 44.29M | -1.61% | 218,460 | 31.80M |
| 434 | HURA | TuHURA Biosciences, Inc. | 44.17M | 1.71% | 345,528 | - |
| 435 | JSPR | Jasper Therapeutics, Inc. | 43.66M | 5.41% | 781,668 | - |
| 436 | TVRD | Tvardi Therapeutics, Inc. | 42.78M | 1.56% | 88,998 | - |
| 437 | CVM | CEL-SCI Corporation | 42.72M | -0.97% | 63,781 | - |
| 438 | OKUR | OnKure Therapeutics, Inc. | 42.54M | -2.18% | 41,261 | - |
| 439 | EVAX | Evaxion A/S | 42.54M | -1.54% | 22,135 | 7.65M |
| 440 | ATNM | Actinium Pharmaceuticals, Inc. | 42.11M | 3.85% | 98,512 | 90.00K |
| 441 | RVPH | Reviva Pharmaceuticals Holdings, Inc. | 41.48M | 9.23% | 3,814,824 | - |
| 442 | QTTB | Q32 Bio Inc. | 41.47M | -7.42% | 124,002 | - |
| 443 | ESLA | Estrella Immunopharma, Inc. | 39.94M | -10.37% | 147,727 | - |
| 444 | INMB | INmune Bio, Inc. | 39.88M | 2.04% | 235,781 | 50.00K |
| 445 | CELU | Celularity Inc. | 39.42M | 3.56% | 66,580 | 40.58M |
| 446 | VERU | Veru Inc. | 38.68M | 6.17% | 295,057 | 16.89M |
| 447 | RNXT | RenovoRx, Inc. | 38.30M | -0.48% | 170,619 | 928.00K |
| 448 | GBIO | Generation Bio Co. | 38.00M | - | 51,829 | 15.27M |
| 449 | XCUR | Exicure, Inc. | 37.80M | 1.54% | 84,088 | 500.00K |
| 450 | IOBT | IO Biotech, Inc. | 37.20M | 2.17% | 600,176 | - |
| 451 | GLTO | Galecto, Inc. | 37.17M | 6.78% | 30,372 | - |
| 452 | LTRN | Lantern Pharma Inc. | 36.46M | -2.98% | 30,140 | - |
| 453 | OTLK | Outlook Therapeutics, Inc. | 35.99M | -2.23% | 3,315,502 | 1.41M |
| 454 | CING | Cingulate Inc. | 35.34M | 1.03% | 99,355 | - |
| 455 | ANTX | AN2 Therapeutics, Inc. | 34.53M | 10.53% | 100,929 | - |
| 456 | GNTA | Genenta Science S.p.A. | 33.27M | 2.16% | 44,898 | - |
| 457 | NRSN | NeuroSense Therapeutics Ltd. | 32.37M | 5.83% | 209,761 | - |
| 458 | CUE | Cue Biopharma, Inc. | 31.99M | 1.62% | 416,386 | 7.10M |
| 459 | JUNS | Jupiter Neurosciences, Inc. | 31.85M | -11.05% | 138,658 | - |
| 460 | DYAI | Dyadic International, Inc. | 31.56M | -5.95% | 72,901 | 3.34M |
| 461 | ATRA | Atara Biotherapeutics, Inc. | 31.51M | -25.68% | 2,496,842 | 151.93M |
| 462 | SKYE | Skye Bioscience, Inc. | 31.42M | 4.13% | 197,866 | - |
| 463 | BRNS | Barinthus Biotherapeutics plc | 31.01M | -0.08% | 59,236 | 14.97M |
| 464 | PLUR | Pluri Inc. | 29.86M | 3.41% | 6,219 | 1.33M |
| 465 | RLYB | Rallybio Corporation | 29.78M | -2.89% | 74,103 | 674.00K |
| 466 | RNTX | Rein Therapeutics Inc. | 29.70M | -1.74% | 62,386 | - |
| 467 | LIXT | Lixte Biotechnology Holdings, Inc. | 29.10M | -1.76% | 73,995 | - |
| 468 | IGC | IGC Pharma, Inc. | 28.68M | -0.20% | 290,111 | 1.11M |
| 469 | MRKR | Marker Therapeutics, Inc. | 28.51M | -6.56% | 520,808 | 4.69M |
| 470 | HYPD | Hyperion DeFi, Inc. | 27.88M | -4.32% | 297,605 | 345.32K |
| 471 | SNTI | Senti Biosciences, Inc. | 27.87M | -5.36% | 273,771 | - |
| 472 | BOLD | Boundless Bio, Inc. | 27.76M | - | 141,664 | - |
| 473 | HOWL | Werewolf Therapeutics, Inc. | 27.74M | -0.56% | 731,675 | 1.14M |
| 474 | DARE | Daré Bioscience, Inc. | 27.58M | -0.52% | 45,037 | -57.13K |
| 475 | VTGN | Vistagen Therapeutics, Inc. | 27.08M | -2.60% | 1,104,517 | 721.00K |
| 476 | QNTM | Quantum BioPharma Ltd. | 26.40M | 6.75% | 55,941 | - |
| 477 | SER | Serina Therapeutics, Inc. | 26.23M | -0.40% | 25,531 | 116.00K |
| 478 | NNVC | NanoViricides, Inc. | 25.88M | 6.19% | 338,461 | - |
| 479 | LONA | LeonaBio, Inc. | 25.79M | -0.15% | 93,650 | - |
| 480 | INTS | Intensity Therapeutics, Inc. | 25.10M | 1.38% | 1,346,733 | - |
| 481 | KLTO | Klotho Neurosciences, Inc. | 23.63M | -5.17% | 1,048,841 | - |
| 482 | LNAI | Lunai Bioworks Inc. | 22.76M | 2.99% | 78,258 | - |
| 483 | FBLG | FibroBiologics, Inc. | 22.51M | -12.17% | 2,763,682 | - |
| 484 | NEUP | Neuphoria Therapeutics Inc. | 22.42M | -0.71% | 33,696 | 15.65M |
| 485 | PLRZ | Polyrizon Ltd. | 22.04M | 0.66% | 150,142 | - |
| 486 | CASI | CASI Pharmaceuticals, Inc. | 21.37M | -3.70% | 12,697 | 26.85M |
| 487 | ALLR | Allarity Therapeutics, Inc. | 21.01M | 6.14% | 168,093 | - |
| 488 | CLGN | CollPlant Biotechnologies Ltd. | 20.95M | 8.61% | 24,534 | 2.48M |
| 489 | BCTX | BriaCell Therapeutics Corp. | 20.64M | 42.93% | 7,414,797 | - |
| 490 | LIMN | Liminatus Pharma, Inc. | 20.54M | -1.45% | 80,252 | - |
| 491 | CVKD | Cadrenal Therapeutics, Inc. | 20.27M | 1.64% | 41,661 | - |
| 492 | KTTA | Pasithea Therapeutics Corp. | 20.22M | -3.26% | 177,926 | - |
| 493 | LEXX | Lexaria Bioscience Corp. | 20.13M | 5.08% | 282,135 | 705.92K |
| 494 | OSRH | OSR Holdings, Inc. | 19.05M | 3.52% | 5,529,672 | -90.52K |
| 495 | VYNE | VYNE Therapeutics Inc. | 18.82M | 0.96% | 394,988 | 524.00K |
| 496 | LSTA | Lisata Therapeutics, Inc. | 18.79M | 2.40% | 36,248 | 1.07M |
| 497 | BCAB | BioAtla, Inc. | 18.19M | -2.07% | 4,478,363 | 11.00M |
| 498 | CTXR | Citius Pharmaceuticals, Inc. | 17.80M | -3.10% | 242,259 | - |
| 499 | ITRM | Iterum Therapeutics plc | 17.75M | 2.44% | 442,861 | 390.00K |
| 500 | PMN | ProMIS Neurosciences, Inc. | 17.56M | -0.61% | 3,283 | - |
| 501 | KALA | KALA BIO, Inc. | 17.21M | -4.83% | 635,751 | - |
| 502 | CLRB | Cellectar Biosciences, Inc. | 17.13M | 6.32% | 286,314 | - |
| 503 | KAPA | Kairos Pharma, Ltd. | 17.08M | -6.79% | 162,498 | - |
| 504 | MTVA | MetaVia Inc. | 17.06M | -5.14% | 81,113 | - |
| 505 | HOTH | Hoth Therapeutics, Inc. | 16.29M | -0.94% | 132,567 | - |
| 506 | APLT | Applied Therapeutics, Inc. | 15.35M | 1.00% | 3,321,028 | 1.00M |
| 507 | COCP | Cocrystal Pharma, Inc. | 15.02M | -1.80% | 65,131 | - |
| 508 | SNSE | Sensei Biotherapeutics, Inc. | 14.83M | 2.98% | 34,606 | - |
| 509 | BCDA | BioCardia, Inc. | 14.75M | -2.11% | 70,436 | 3.00K |
| 510 | NCNA | NuCana plc | 14.69M | 6.97% | 463,301 | - |
| 511 | GDTC | CytoMed Therapeutics Limited | 14.08M | -1.61% | 198,781 | 573.19K |
| 512 | SNGX | Soligenix, Inc. | 13.82M | - | 77,594 | 2.34K |
| 513 | TPST | Tempest Therapeutics, Inc. | 13.45M | -4.55% | 63,368 | - |
| 514 | GRDX | GridAI Technologies Corp. | 13.28M | -2.47% | 128,261 | - |
| 515 | MBRX | Moleculin Biotech, Inc. | 13.21M | 5.93% | 283,343 | - |
| 516 | SYBX | Synlogic, Inc. | 13.10M | -0.88% | 8,924 | 8.00K |
| 517 | IMNN | Imunon, Inc. | 12.92M | 6.74% | 80,777 | - |
| 518 | AEON | AEON Biopharma, Inc. | 12.90M | -0.95% | 200,006 | - |
| 519 | TRAW | Traws Pharma, Inc. | 12.87M | 26.77% | 1,416,765 | 2.85M |
| 520 | AKTX | Akari Therapeutics, Plc | 12.78M | 1.49% | 217,355 | - |
| 521 | PHIO | Phio Pharmaceuticals Corp. | 12.70M | -0.84% | 115,955 | - |
| 522 | BLRX | BioLineRx Ltd. | 12.46M | 0.35% | 30,091 | 12.74M |
| 523 | EDSA | Edesa Biotech, Inc. | 12.33M | - | 34,682 | - |
| 524 | LGVN | Longeveron Inc. | 11.69M | -4.14% | 172,619 | 1.44M |
| 525 | CRIS | Curis, Inc. | 11.59M | -2.03% | 601,177 | 11.65M |
| 526 | BOLT | Bolt Biotherapeutics, Inc. | 11.50M | 3.10% | 28,266 | 5.20M |
| 527 | NCEL | NewcelX Ltd. | 11.26M | -0.80% | 141,966 | - |
| 528 | CMMB | Chemomab Therapeutics Ltd. | 11.02M | -2.19% | 33,297 | - |
| 529 | ABP | Abpro Holdings, Inc. | 10.57M | -0.77% | 4,790 | 183.00K |
| 530 | XTLB | XTL Biopharmaceuticals Ltd. | 10.53M | 56.66% | 36,308,629 | 968.00K |
| 531 | BRTX | BioRestorative Therapies, Inc. | 10.47M | -0.19% | 15,760 | 383.40K |
| 532 | ICU | SeaStar Medical Holding Corporation | 10.35M | 24.78% | 666,615 | 881.00K |
| 533 | INAB | IN8bio, Inc. | 10.06M | -0.46% | 77,706 | - |
| 534 | ERNA | Ernexa Therapeutics Inc. | 9.73M | -4.62% | 13,831 | 1,000.00 |
| 535 | EVGN | Evogene Ltd. | 9.67M | -4.63% | 63,479 | 8.02M |
| 536 | BIVI | BioVie Inc. | 9.57M | 0.79% | 55,413 | - |
| 537 | PMCB | PharmaCyte Biotech, Inc. | 9.21M | 1.26% | 244,194 | - |
| 538 | QNRX | Quoin Pharmaceuticals, Ltd. | 9.15M | -6.90% | 26,239 | - |
| 539 | ALZN | Alzamend Neuro, Inc. | 9.01M | 1.72% | 63,923 | - |
| 540 | APVO | Aptevo Therapeutics Inc. | 8.86M | -1.00% | 101,612 | - |
| 541 | APM | Aptorum Group Limited | 8.71M | 2.88% | 76,761 | - |
| 542 | ASBP | Aspire Biopharma Holdings, Inc. | 8.58M | -16.00% | 37,426,079 | 1.94K |
| 543 | PULM | Pulmatrix, Inc. | 8.51M | -0.85% | 7,507 | 3.00K |
| 544 | ADXN | Addex Therapeutics Ltd | 8.34M | -3.89% | 112,240 | 198.82K |
| 545 | CLDI | Calidi Biotherapeutics, Inc. | 8.05M | -1.77% | 197,320 | - |
| 546 | KPRX | Kiora Pharmaceuticals, Inc. | 8.03M | 0.92% | 23,415 | 20.00K |
| 547 | DCOY | Decoy Therapeutics Inc. | 7.98M | 53.37% | 108,758,682 | - |
| 548 | MBIO | Mustang Bio, Inc. | 7.96M | -1.80% | 42,051 | - |
| 549 | RNAZ | TransCode Therapeutics, Inc. | 7.83M | 7.42% | 33,584 | - |
| 550 | IMRN | Immuron Limited | 7.82M | 22.95% | 564,010 | 4.78M |
| 551 | TOVX | Theriva Biologics, Inc. | 7.52M | -3.21% | 1,608,800 | - |
| 552 | PCSA | Processa Pharmaceuticals, Inc. | 7.30M | 2.55% | 74,551 | - |
| 553 | GTBP | GT Biopharma, Inc. | 7.29M | -6.11% | 745,804 | - |
| 554 | PPBT | Purple Biotech Ltd | 7.10M | -1.84% | 49,846 | - |
| 555 | BGMS | Bio Green Med Solution, Inc. | 6.81M | 6.92% | 42,178 | 81.00K |
| 556 | SLXN | Silexion Therapeutics Corp | 6.60M | -0.47% | 38,246 | - |
| 557 | ACXP | Acurx Pharmaceuticals, Inc. | 6.41M | -1.80% | 52,741 | - |
| 558 | CELZ | Creative Medical Technology Holdings, Inc. | 6.36M | -11.22% | 602,955 | 6.00K |
| 559 | APRE | Aprea Therapeutics, Inc. | 6.31M | -1.90% | 98,439 | 488.24K |
| 560 | ADIL | Adial Pharmaceuticals, Inc. | 6.28M | -3.05% | 249,206 | - |
| 561 | GOVX | GeoVax Labs, Inc. | 5.98M | - | 154,175 | 3.35M |
| 562 | TCRT | Alaunos Therapeutics, Inc. | 5.85M | -8.07% | 57,490 | 6.00K |
| 563 | CYCN | Cyclerion Therapeutics, Inc. | 5.82M | -10.53% | 204,888 | 2.86M |
| 564 | PPCB | Propanc Biopharma, Inc. | 5.79M | -4.33% | 83,879 | - |
| 565 | CANF | Can-Fite BioPharma Ltd. | 5.61M | -2.59% | 47,650 | 560.00K |
| 566 | GNPX | Genprex, Inc. | 5.57M | -7.69% | 993,059 | - |
| 567 | REVB | Revelation Biosciences, Inc. | 5.36M | 0.58% | 68,486 | - |
| 568 | INDP | Indaptus Therapeutics, Inc. | 5.34M | -3.17% | 55,265 | - |
| 569 | VIVS | VivoSim Labs, Inc. | 5.24M | -0.50% | 4,085 | 140.00K |
| 570 | SILO | Silo Pharma, Inc. | 5.13M | -2.58% | 129,937 | 72.10K |
| 571 | XBIO | Xenetic Biosciences, Inc. | 5.06M | -3.75% | 32,996 | 2.86M |
| 572 | MTNB | Matinas BioPharma Holdings, Inc. | 4.77M | 14.46% | 85,311 | - |
| 573 | GLMD | Galmed Pharmaceuticals Ltd. | 4.55M | -0.66% | 27,368 | - |
| 574 | SPRC | SciSparc Ltd. | 4.01M | -15.52% | 40,455,189 | 1.31M |
| 575 | XRTX | XORTX Therapeutics Inc. | 4.01M | 3.32% | 25,406 | - |
| 576 | ENVB | Enveric Biosciences, Inc. | 3.85M | -1.57% | 45,505 | - |
| 577 | CNSP | CNS Pharmaceuticals, Inc. | 3.81M | 2.16% | 8,713 | - |
| 578 | OGEN | Oragenics, Inc. | 3.66M | 2.24% | 11,457 | - |
| 579 | CMND | Clearmind Medicine Inc. | 3.66M | 12.96% | 68,813 | - |
| 580 | LYRA | Lyra Therapeutics, Inc. | 3.53M | -3.40% | 247,285 | 600.00K |
| 581 | PHGE | BiomX Inc. | 3.47M | 0.89% | 19,358 | - |
| 582 | ENSC | Ensysce Biosciences, Inc. | 3.36M | 2.24% | 137,788 | 4.49M |
| 583 | CDIO | Cardio Diagnostics Holdings, Inc. | 3.34M | -5.67% | 191,088 | 15.78K |
| 584 | HCWB | HCW Biologics Inc. | 3.24M | -1.64% | 30,709 | 422.03K |
| 585 | JAGX | Jaguar Health, Inc. | 3.14M | -16.75% | 2,908,577 | 11.79M |
| 586 | ARTL | Artelo Biosciences, Inc. | 3.05M | 7.86% | 162,916 | - |
| 587 | GRI | GRI Bio, Inc. | 3.00M | -11.07% | 1,821,980 | - |
| 588 | AZTR | Azitra, Inc. | 2.96M | -9.60% | 1,095,919 | 7.50K |
| 589 | BBLG | Bone Biologics Corporation | 2.93M | -1.21% | 17,058 | - |
| 590 | SCNI | Scinai Immunotherapeutics Ltd. | 2.88M | 6.59% | 34,368 | 1.15M |
| 591 | DRMA | Dermata Therapeutics, Inc. | 2.49M | 16.48% | 283,851 | - |
| 592 | CDT | CDT Equity Inc. | 2.43M | -4.76% | 38,073 | - |
| 593 | ONCO | Onconetix, Inc. | 2.30M | -7.50% | 33,763 | 1.22M |
| 594 | VRAX | Virax Biolabs Group Limited | 2.30M | -9.36% | 252,546 | 2.99K |
| 595 | SXTP | 60 Degrees Pharmaceuticals, Inc. | 2.23M | -7.62% | 265,079 | 1.36M |
| 596 | BDRX | Biodexa Pharmaceuticals Plc | 1.92M | -1.72% | 112,964 | 104.90K |
| 597 | PBM | Psyence Biomedical Ltd. | 1.46M | -1.54% | 215,530 | - |
| 598 | ADTX | Aditxt, Inc. | 1.33M | -8.21% | 267,992 | 5.95K |
| 599 | MLEC | Moolec Science SA | 1.31M | 19.46% | 745,730 | 7.83M |
| 600 | ELAB | PMGC Holdings Inc. | 747.84K | -23.72% | 530,788 | 285.95K |